The U.S. clinical laboratory services market expands through regulatory-driven compliance investments, precision-genomics ...

HepQuant, LLC, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, is proud to announce ISO 13485 certification as its latest milestone in operational ...

Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with ...

Cepheid today announced that Health Canada has issued Cepheid a medical device licence for Xpert® HIV-1 Viral Load XC, a next-generation extended-coverage (XC) test intended to aid in assessing HIV ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...

The overturning of the FDA’s lab-developed tests rule is just the tip of the iceberg. With the loss of Chevron deference, ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis ... including a look at pre-specified subgroups, longer-term clinical effects, and effects on ALS biomarkers, including ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...